Does bone cancer in young people need a more targeted type of immunotherapy?
Osteosarcoma needs intensive treatment and can become untreatable for around half of patients. Immunotherapy could be a tempting new option for these patients.
Osteosarcoma needs intensive treatment and can become untreatable for around half of patients. Immunotherapy could be a tempting new option for these patients.
Children’s Cancer and Leukaemia Group has funded two new research projects that support non-traditional researchers trying to improve childhood cancer care.
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to Southampton to find out...
The family behind the Harley Staples Cancer Trust (HSCT) visited the University of Leeds earlier this week to learn more about acute lymphoblastic leukaemia (ALL) research they funded through Children’s Cancer and Leukaemia Group (CCLG) in 2023.
Children's Cancer and Leukaemia Group Special Named Fund, A Goal for Sam, funds new leukaemia research.
Hear from Dr Jonathan Fisher about how immunotherapy could help children with solid tumours.
There is a lot more to research than just scientists in white lab coats. We caught up with some of the amazing parents who help shape the direction of childhood cancer research.
New research into acute myeloid leukaemia (AML) has been funded, thanks to two Children’s Cancer and Leukaemia Group (CCLG) Special Named Funds.
Researching rare cancers can be very difficult, because researchers need lots of data to work on. In atypical teratoid rhabdoid tumours, the latest clinical trial has been vital for new research.